Dr. Niraj Bhatt Medical Oncologist in Vadodara

Dr. Niraj Bhatt

Medical Oncologist, Vadodara

MD, DM Medical oncology

  • 22 Years Experience
  • 1 Hospital
  • 1 Private Practice

About

Dr. Niraj Bhatt is a consultant Medical Oncologist associated with Cancer Care clinic, Vadodara.

Specialities

  • Medical Oncology

  • Hemato Oncology

  • Oncology

Expertise


Education

MBBS, 1998, MS University, Vadodara

MD (General Medicine), 2003, Gujarat University, Ahmedabad

DM (Oncology), 2006, Gujarat Cancer and Research Institute, Ahmedabad

Practice Information

Sterling Hospitals, Vadodara

Sterling Hospitals, Vadodara

Opp INOX Cinema, Race Course, Vadodara, Gujarat - 390007

Private Practice Information

Cancer care clinic

Cancer care clinic

1st floor, Pratham complex, Laxmi hall lane, sampatrao colony, Vadodara

  • (0265) 2328880

Achievements & Contributions

  • Phase I Clinical Trial: Metastatic breast cancer. [Principal Investigator]
  • Phase II Clinical Trial: Non-small lung cancer and colorectal cancer. [Principal Investigator]
  • Bioequivalence – Clinical Trial: Metastatic breast cancer and colorectal cancer. [Principal Investigator]
  • Bioequivalence – Clinical Trial: Metastatic breast cancer and colorectal cancer. [Principal Investigator]
  • Phase I Clinical Trial: Advanced solid malignancy. [Principal Investigator]
  • Phase II Clinical Trial: Non-small cell lung cancer. [Principal Investigator]
  • Phase III Clinical Trial: Breast cancer. [Principal Investigator]
  • Bioequivalence – Clinical Trial: Acute lymphoblastic leukaemia. [Principal Investigator]
  • Bioequivalence – Clinical Trial: CML and GIST. [Principal Investigator]
  • Phase III Clinical Trial: Metastatic breast cancer. [Principal Investigator]
  • Phase III Clinical Trial: Diffuse large B cell lymphoma. [Principal Investigator]
  • Phase II Clinical Trial: Metastatic colorectal cancer. [Principal Investigator]
  • Cetuximab - Targeted therapy in colorectal cancer. Indian Journal of Clinical Practice. Aug 2005.
  • Phase I PK, dose finding active controlled study of PICN in metastatic breast cancer patients. American Society of Clinical Oncology. 2011.
  • Phase I study of Docetaxel injection concentrate for Nano dispersion (DICN), a novel Polysorbate 80- free formulation of Docetaxel. American Society of Clinical Oncology. 2012.
  • Indian medical association
-->